Stay updated on AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous v3.6.5. This indicates a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-09-01T19:34:53.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The sponsor is updated to Immedica Pharma AB, and the study overview has been refreshed to reflect a first-in-human, phase 1 dose-escalation trial of AEB1102 (Co-ArgI-PEG). New expansion cohorts were added for Cutaneous Melanoma, Uveal Melanoma, and Small Cell Lung Cancer, dosed at 0.33 mg/kg, with corresponding enrollment details and updated timelines.
    Difference
    3%
    Check dated 2026-08-11T15:17:38.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page metadata revision label updated from v3.6.3 to v3.6.4, indicating a small version bump.
    Difference
    0.0%
    Check dated 2026-07-28T05:41:41.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page revision label now shows v3.6.3, indicating a minor release update to the ClinicalTrials.gov study page.
    Difference
    0.0%
    Check dated 2026-07-06T10:53:11.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2, indicating a software maintenance release. It represents an underlying update to the site's system rather than a new content addition.
    Difference
    0.0%
    Check dated 2026-06-29T09:54:56.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    New help/navigation entries such as How to Read a Study Record, Common Questions, and How to Join a Study were added, and 'No longer looking for participants' indicates the study is no longer enrolling. The 'Intervention/Treatment' heading formatting was adjusted, while the older 'Intervention / Treatment' label and the older revision note were removed; a Revision: v3.6.0 tag was introduced.
    Difference
    0.4%
    Check dated 2026-06-15T08:18:08.000Z thumbnail image

Stay in the know with updates to AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page.